Odronic Shelley I, Roberson Janie, Booth Christine N
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio.
Department of Pathology, University of Alabama, Birmingham, Alabama.
J Am Soc Cytopathol. 2015 Sep-Oct;4(5):239-245. doi: 10.1016/j.jasc.2015.02.005. Epub 2015 Feb 23.
The American Society of Cytopathology Clinical Practice Committee in collaboration with the American Society of Cytotechnology surveyed cytology practitioners to better understand current practices related to nongynecologic (NGYN) cytology. While work practices in gynecologic (GYN) cytology are highly regulated with limited variation among specimens and processing techniques, practice patterns for NGYN cytology are less standardized among laboratories.
An NGYN cytology survey was created that consisted of 40 questions focusing on 6 main topic areas: (1) practice settings and demographic data; (2) NGYN non-fine-needle aspiration cytology; (3) fine-needle aspiration (FNA) cytology; (4) rapid on-site evaluation practices; (5) workload recording practices; and (6) expanding roles of the cytotechnologist (CT). The survey was sent to all American Society of Cytopathology and American Society of Cytotechnology members and remained available for 40 days.
There were 368 survey participants (14% response rate) with nearly equal participation among CTs, cytology general managers and/or supervisors, and pathologists representing a variety of practice types. Most laboratories (87%) are providing a rapid on-site evaluation service for FNA specimens. The role of CTs is expanding with the majority of respondents stating that CTs assist with both clinician-performed and pathologist-performed FNA acquisition (77% and 50%, respectively), telecytology (16%), and screening of ancillary studies, including special stains (64%), immunohistochemistry (23%), and fluorescence in situ hybridization (16%).
Knowledge of NGYN cytology practice patterns among laboratories may contribute information to better define the future of cytotechnology, support reimbursement initiatives, and enhance quality and efficiencies in the cytology laboratory.
美国细胞病理学学会临床实践委员会与美国细胞技术学会合作,对细胞病理学从业者进行了调查,以更好地了解与非妇科(NGYN)细胞学相关的当前实践。虽然妇科(GYN)细胞学的工作实践受到高度规范,标本和处理技术之间的差异有限,但NGYN细胞学的实践模式在各实验室之间的标准化程度较低。
创建了一项NGYN细胞学调查,包括40个问题,重点关注6个主要主题领域:(1)实践环境和人口统计学数据;(2)NGYN非细针穿刺细胞学;(3)细针穿刺(FNA)细胞学;(4)快速现场评估实践;(5)工作量记录实践;以及(6)细胞技术人员(CT)角色的扩展。该调查发送给了美国细胞病理学学会和美国细胞技术学会的所有成员,并开放了40天。
共有368名调查参与者(回复率为14%),CT、细胞学总经理和/或主管以及代表各种实践类型的病理学家的参与人数几乎相等。大多数实验室(87%)为FNA标本提供快速现场评估服务。CT的角色正在扩展,大多数受访者表示CT协助临床医生和病理学家进行FNA采集(分别为77%和50%)、远程细胞学(16%)以及辅助研究的筛查,包括特殊染色(64%)、免疫组织化学(23%)和荧光原位杂交(16%)。
了解各实验室中NGYN细胞学的实践模式可能有助于提供信息,以更好地定义细胞技术的未来、支持报销倡议,并提高细胞学实验室的质量和效率。